Clinical and Molecular Response Assessed in Peripheral Blood in 194 Patients With FL at Different Time Points From the Beginning of Treatment
| Time Points . | No. of Patients . | Clinical CR Rate (%) . | Molecular Response Rate (%) . |
|---|---|---|---|
| 3-5 mo | 118 | 29 | 37 |
| 6-8 mo | 86 | 63 | 53 |
| 9-14 mo | 101 | 86 | 56 |
| 15-19 mo | 74 | 97 | 66 |
| Time Points . | No. of Patients . | Clinical CR Rate (%) . | Molecular Response Rate (%) . |
|---|---|---|---|
| 3-5 mo | 118 | 29 | 37 |
| 6-8 mo | 86 | 63 | 53 |
| 9-14 mo | 101 | 86 | 56 |
| 15-19 mo | 74 | 97 | 66 |
The number of patients varies at different time points because occasional patients did not have clinical or molecular assessment of response at a given time point.